3Sablotzki A, Hent schel T, Hofmann S ,et al. Inhaled aerosolized iloprost in t he evaluation of heart t ransplant candidates -experiences with 45 cases. J Clin Anesth,2006,18 : 1082113.
4Peter N K. Simvastatin t reatment of pulmonary hypertension: an observational case serieS. Chest, 2005,127 : 1446 - 1452.
5Ishikura K, Yamada N, ItO M, et al. Beneficial acute effect s of Rho2kinase inhibitor in patient s wit h pulmonary arterial hy2pertension. Circ J, 2006., 70 : 1742178.
6Stenmark KR, McMurt ry IF. Vascular remodeling versus vasoconst fiction in chronic hypoxic pulmonary hypertension: Atime for reappraisal. Cir Res, 2005, 97:95298.
73rd World PAH Symposium. Pulmonary arterial hypertension: epidemiology, pat hobiology, assessment and therapy. J Am Coll Cardiol,2004,43 : 1290.
8Marcos E, Adnot S, Pham MH, et al. Serotonin transporter inhibitors protectagainst hypoxic pulmonary hypertension. Am J Respir Crit Care Med, 2003, 168 (3) :487-493.
9Kawut SM, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol,2005,95 (2) : 1991.
